Methylphenidat-Mepha 18 mg
Methylphenidat-Mepha 18 mg is a medicine authorised by Swissmedic under authorisation number 66445. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 09 August 2017 and the authorisation is valid without a time limit. ATC code N06BA04 places the medicine in the group Psychoanaleptics.
| Authorisation number | 66445 |
|---|---|
| Name | Methylphenidat-Mepha 18 mg |
| Full name | Methylphenidat-Mepha 18 mg, Retardtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N06BA04 |
| First authorisation | 09 August 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Methylphenidat-Mepha 18 mg, Retardtabletten | A+ | 09 August 2017 |
| 2 | Methylphenidat-Mepha 27 mg, Retardtabletten | A+ | 09 August 2017 |
| 3 | Methylphenidat-Mepha 36 mg, Retardtabletten | A+ | 09 August 2017 |
| 4 | Methylphenidat-Mepha 54 mg, Retardtabletten | A+ | 09 August 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 2 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 3 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 4 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 5 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 6 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 7 | 30 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
| 8 | 60 | Tablette(n) | N06BA04 | 01.10.2. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Methylphenidat-Mepha 18 mg authorised in Switzerland?
Yes. Methylphenidat-Mepha 18 mg is authorised by Swissmedic under authorisation number 66445, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Methylphenidat-Mepha 18 mg have?
Methylphenidat-Mepha 18 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Methylphenidat-Mepha 18 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.